Control Bionics Launches World-Class Multi-Modal Augmentative and Alternative Communications (AAC) Device for Those with Speech and Motor Disorders With Unique Combination of Technologies, New GridPad
To Our Clients, Caregivers, and Clinicians: As we’ve globally transitioned into telepresence communication, we will still be offering our remote assessments alongside our industry-leading customer
Your NeuroNode Trilogy should be cleaned and disinfected on a regular basis. We recommend Super Sani-Cloth Germicidal Disposable Wipes for this. While Control Bionics routinely
Control Bionics was founded by Peter Shann Ford in 2006 to address the most difficult cases of loss of speech and mobility. Ford and the
The NeuroNode Trilogy provides three access methods in a single funding accessible solution for degenerative conditions. MILFORD, OH – Feb.5, 2019 – Control Bionics Launches
Successful NeuroNode Performance Trial with Maeve, a 3rd Grade Student with Spinal Muscular Atrophy (SMA), Leads to Acquisition of seven NeuroNodes by NYC DOE’s Center for
Kristin Harley, diagnosed with motor neurone disease in early 2013, makes the tough choice to have a tracheostomy. While she has been using the NeuroNode at home for the
The NeuroNode provides a new solution for those with ALS/MND, Cerebral Palsy and more. Milford, Ohio, October 26, 2018 — Control Bionics’ NeuroNode, a revolutionary life-altering
Control Bionics will be launching a revolutionary wireless, wearable EMG device complete with hands-free, voice-free Google Assistant control for the disabled population at the Closing
USA
745 Center Street, Suite 303
Milford OH 45150
AUSTRALIA
171 Union Road, Suite G.03
Surrey Hills VIC 3127
CANADA
Bridges Canada
2123 McCowan Road
Scarborough, Ontario M1S 3Y6
©2012-2021 Control Bionics, Inc. All Rights Reserved
